Greenwich LifeSciences Statistics
NASDAQ: GLSIHealth CareBiotechnology: Pharmaceutical PreparationsUSD
14.65-0.74 (-4.81%)
Market open · Delayed 15 min · as of Oct 8, 1:37 PM ET
Greenwich LifeSciences by the numbers
Greenwich LifeSciences has a market capitalization of $215.0 million based on 14.68M shares outstanding. With trailing EPS of $-1.53, Greenwich LifeSciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 10.5% below its 50-day average and 33.3% below its 200-day average.
Average daily trading volume is 138.72K shares, or about $2.0 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
GLSI valuation vs. peer median
| Metric | GLSI | Peer median | Difference |
|---|---|---|---|
| Market cap | $215.04M | $227.90M | -6% |
| Avg. volume | 138.72K | 659.86K | -79% |
Peer median across 8 companies: KROS, SLGL, AKBA, MGNX, EVMN, PRQR, CAMP, SION.
Valuation
- Market cap
- $215.04M
- EPS (TTM)
- $-1.53
- Shares outstanding
- 14.68M
Price and trading
- Previous close
- 15.39
- Open
- 15.07
- Day range
- 14.58 – 16.14
- 52-week range
- 7.78 – 34.10
- 52-week change
- +37.04%
- Beta
- —
- Volume
- 55.58K
- Average volume
- 138.72K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 12, 2026
Additional statistics
- Market Cap
- 215.04M
- Forward Pe
- -17.87
- Eps
- -1.53
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 34.10
- Week52 Low
- 7.78
- Avg Volume
- 138.72K
- Shares Outstanding
- 14.68M
- Ma50
- 16.37
- Ma200
- 21.97
- Earnings Date
- Nov 12, 2026
- Pct From52w High
- -57.04%
- Pct From52w Low
- 88.30%